|
|
|
富蘭克林生技領航基金-B/累積
(美元)
| 幣別 |
淨值 |
漲跌 |
漲跌比例 |
日期 |
| 美元 |
23.61 |
0.42 |
1.81% |
2019/08/16 |
|
|
| 2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
| 9.54% |
15.99% |
8.18% |
25.28% |
62.03% |
32.92% |
3.61% |
-18.98% |
15.42% |
-17.40% |
| 富蘭克林生技領航基金-B/累積(美元)
基金資料
基金月報
|
|
● 以美國為主 - 美國生技廠商具產品及技術領先優勢且美國為全球最大藥品市場，本基金目前在美國投資比重超過九成 (2013/8月底)。
● 掌握生技技術領導產業 - 大型藥廠與生技公司間進行購併及技術合作的趨勢明確，具研發利基的公司將因而受惠。
● 兼具成長與價值的投資策略 - 採取由下而上的方式，選擇具發展潛力、技術領先且臨床數據及市場發展策略良好的個股進行投資。
● 地利之便，掌握生技產業脈動 - 富蘭克林研究團隊位居加州，緊鄰舊金山生技園區，地利之便能夠掌握生技產業最新脈動。
● 榮獲2012年及2013年Smart智富台灣基金獎(晨星技術指導)「生物科技和健康護理股票型基金獎」，2011年及2012年香港指標雜誌基金大獎「最佳生物科技行業股票基金」
● 晨星基金績效評等四顆星(2013/8月)
|
| 日期 |
淨值 |
漲跌比例 |
日期 |
淨值 |
漲跌比例 |
| 2019/08/16 |
23.61 |
1.81% |
2019/08/01 |
24.42 |
0.45% |
| 2019/08/15 |
23.19 |
-0.39% |
2019/07/31 |
24.31 |
-0.78% |
| 2019/08/14 |
23.28 |
-2.43% |
2019/07/30 |
24.50 |
0.74% |
| 2019/08/13 |
23.86 |
0.85% |
2019/07/29 |
24.32 |
-0.33% |
| 2019/08/12 |
23.66 |
-1.29% |
2019/07/26 |
24.40 |
1.20% |
| 2019/08/09 |
23.97 |
1.61% |
2019/07/25 |
24.11 |
-1.87% |
| 2019/08/07 |
23.59 |
0.43% |
2019/07/24 |
24.57 |
0.12% |
| 2019/08/06 |
23.49 |
1.38% |
2019/07/23 |
24.54 |
-0.37% |
| 2019/08/05 |
23.17 |
-3.34% |
2019/07/22 |
24.63 |
0.37% |
| 2019/08/02 |
23.97 |
-1.84% |
2019/07/19 |
24.54 |
-1.60% |
基金績效 (可點按欄位名稱排序)
| 名稱 |
一日 |
一週 |
一個月 |
三個月 |
六個月 |
一年 |
今年以來 |
|
1.81% |
-1.50% |
-4.30% |
0.00% |
-3.51% |
-8.91% |
13.29% |
| NBI生技指數 |
2.23% |
-0.41% |
-0.52% |
0.52% |
-6.29% |
-9.84% |
8.40% |
| 費城藥物指數 |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| AMEX生技指數 |
0.00% |
0.00% |
-1.90% |
0.76% |
-8.70% |
-10.11% |
8.16% |
| MSCI 全球醫療保健指數 (price) |
0.00% |
-1.98% |
-2.24% |
1.53% |
-2.11% |
-1.05% |
5.14% |
| MSCI 製藥指數 (price) |
0.00% |
-2.14% |
-1.76% |
-0.46% |
-3.08% |
-1.65% |
2.28% |
| MSCI 生物科技指數 (price) |
0.00% |
-1.20% |
-0.96% |
-1.54% |
-8.44% |
-13.27% |
-3.84% |
|
1.35% |
-1.28% |
-1.82% |
2.32% |
-2.32% |
0.71% |
7.12% |
|
1.34% |
-1.30% |
-1.91% |
2.06% |
-2.80% |
-0.29% |
6.45% |
|
0.71% |
-1.77% |
-2.02% |
0.68% |
-4.47% |
-7.23% |
12.71% |
|
0.03% |
-2.85% |
-2.20% |
1.09% |
-5.87% |
-9.57% |
8.41% |
|
0.43% |
0.02% |
1.31% |
7.31% |
5.57% |
9.80% |
14.82% |
|
-0.28% |
-0.99% |
0.07% |
6.28% |
3.80% |
6.70% |
11.28% |
|
1.13% |
-1.13% |
-0.69% |
4.20% |
-0.08% |
-2.59% |
10.18% |
|
0.82% |
-0.62% |
0.76% |
5.07% |
2.11% |
1.72% |
12.31% |
|
0.95% |
-0.66% |
-0.30% |
4.39% |
0.44% |
0.04% |
10.01% |
|
0.32% |
0.49% |
3.89% |
9.56% |
11.67% |
-0.86% |
19.55% |
|
1.13% |
0.91% |
1.75% |
7.18% |
6.66% |
8.88% |
16.41% |
|
1.78% |
-1.50% |
-4.21% |
0.33% |
-2.89% |
-7.72% |
14.20% |
|
-1.61% |
-1.99% |
-2.72% |
3.92% |
1.91% |
2.97% |
12.30% |
|
1.34% |
-1.07% |
-1.84% |
1.79% |
-0.47% |
0.26% |
11.66% |
|
1.34% |
-1.10% |
-1.93% |
1.53% |
-0.96% |
-0.71% |
10.96% |
|
1.33% |
-1.14% |
-2.10% |
0.90% |
-2.13% |
-3.13% |
9.30% |
|
1.33% |
-1.11% |
-2.03% |
1.10% |
-1.74% |
-2.37% |
9.82% |
|
1.34% |
-1.06% |
-1.76% |
2.01% |
-0.07% |
1.03% |
12.21% |
|
-0.06% |
-1.54% |
-0.12% |
2.91% |
-1.89% |
-5.78% |
8.90% |
|
0.53% |
-1.60% |
-3.50% |
-0.65% |
-3.29% |
-8.11% |
12.00% |
|
1.28% |
-0.52% |
-2.06% |
1.13% |
0.02% |
-2.04% |
18.15% |
|
0.55% |
-1.54% |
-3.28% |
0.14% |
-1.68% |
-4.83% |
14.47% |
|
0.01% |
-1.09% |
-1.20% |
2.95% |
-0.52% |
-2.44% |
9.76% |
|
0.75% |
-0.00% |
0.28% |
4.83% |
2.90% |
3.79% |
15.73% |
|
0.02% |
-1.04% |
-0.96% |
3.80% |
1.14% |
0.83% |
12.11% |
|
-2.14% |
-0.65% |
-3.11% |
1.72% |
-5.96% |
-8.92% |
9.92% |
|
-2.07% |
-0.57% |
-2.64% |
3.60% |
2.64% |
-0.16% |
11.99% |
|
1.25% |
-2.02% |
0.00% |
3.19% |
-0.21% |
-3.77% |
11.49% |
|
1.45% |
-2.23% |
-2.23% |
2.04% |
-2.23% |
-4.63% |
9.72% |
| 基金平均績效 |
0.61% |
-1.08% |
-1.36% |
2.91% |
-0.14% |
-1.58% |
11.91% |
* 基金報酬率包含配息
(若未註明"*"，則基金報酬率不包含配息，對於有配息之基金，將造成總報酬率數值低估。)
本資訊僅供參考，實際數據以官方公佈資料為準。 本站自當盡力為使用者提供正確的意見及消息，但如有錯漏或疏忽，本站恕不負任何法律責任。
|
